Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide is approved in the UK as a once-weekly subcutaneous injection, and the standard route for most patients is the pre-filled Wegovy pen rather than a separate syringe. If you have been directed by your prescriber to draw semaglutide from a vial into a syringe, the technique matters: correct site selection, aseptic preparation and the right subcutaneous angle are what the NHS semaglutide guidance bases safe use on. These are prescription-only medicines, and a prescriber decides both whether they're appropriate for you and how they're administered.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy Summary of Product Characteristics, held on the electronic Medicines Compendium, describes subcutaneous administration as the licensed route for semaglutide in weight management. Subcutaneous means beneath the skin, into the fatty layer that sits above muscle. The STEP 1 trial (which enrolled over 1,900 adults and found an average of around 15% body-weight reduction over 68 weeks) used this route throughout, and it's the delivery method all the clinical evidence is built around.
When semaglutide is drawn into a syringe from a vial rather than delivered via the Wegovy pre-filled pen, the pharmacological effect is identical. The difference is procedural: you are responsible for drawing the correct volume, expelling air, and controlling the injection depth yourself, which is why our step-by-step guide to giving a semaglutide injection with a syringe is worth reading alongside your prescriber's instructions. That's why your prescriber's specific instructions take precedence over any general guide, including this one. If anything in the process feels unclear, contact your clinical team before injecting.
One thing the SmPC is explicit about: semaglutide must never be injected into a vein or muscle. Intravenous or intramuscular delivery changes absorption kinetics and is not what the medicine is licensed for.
Wash your hands thoroughly before handling the vial, syringe or needle. Check the vial: semaglutide solution should be clear and colourless to slightly yellow. If it looks cloudy, contains visible particles, or has been frozen, do not use it, contact your prescriber or pharmacy.
Draw the volume your prescriber specified. Hold the syringe upright and gently tap to bring any air bubbles to the top, then push the plunger slowly to expel them. A small air bubble that won't clear is generally not dangerous when injecting subcutaneously, but understanding what to do with an air bubble in a semaglutide syringe is worth reading before your first injection.
Choose your site. The abdomen is the most commonly used and tends to have a reliable layer of subcutaneous tissue. The front or outer thigh works well too. Avoid bruised, broken, tender or scarred skin. Clean the area with a fresh alcohol swab and let it dry, ten seconds is usually enough, but rushing this step causes unnecessary stinging.
Pinch a fold of skin gently if you have less subcutaneous tissue (for example, on a lean thigh), and insert the needle at around 45 degrees. If there's a reasonable amount of tissue, 90 degrees is fine. Inject slowly and steadily, release the skin fold, then withdraw the needle at the same angle you inserted it. Apply gentle pressure with a clean cotton pad; don't rub, as that can affect absorption.
Rotating your injection site each week isn't optional. Using the same spot repeatedly leads to lipohypertrophy (small lumps of thickened tissue) which slows and unpredictably changes drug absorption. A simple rotation pattern, such as moving clockwise around the abdomen or alternating thighs week by week, makes this easy to track.
Storage matters as much as technique. Semaglutide vials and pens should be kept refrigerated between 2°C and 8°C. The exact guidance on how long a vial may be kept at room temperature before it must be discarded is in the Patient Information Leaflet, not a detail to guess at. If you're planning to travel, travelling with semaglutide requires some forethought around cold-chain logistics, especially for longer trips.
Dispose of each used needle and syringe immediately into a hard-sided sharps container. Pharmacies can supply these; a one-litre sharps container is practical for home use and complies with UK clinical waste requirements. Most councils collect them via a sharps bin exchange scheme.
If you notice unusual redness, swelling or pain that doesn't settle within a day or two at an injection site, speak to your prescriber. Side effects beyond the injection site (particularly nausea, which is the most reported effect as the dose increases) are usually mild and settle within the first week or two of a new dose level. Severe or persistent stomach pain, especially if it reaches through to the back, needs prompt medical attention: the MHRA's Drug Safety Update from January 2026 flagged acute pancreatitis as a known infrequent but serious risk with GLP-1 medicines.
The Patient Information Leaflet covers the essentials, but it can't anticipate every scenario. A common one our prescribers hear: what to do with a missed dose when you've drawn the syringe but not injected. The answer depends on timing and is something your prescriber or clinical team should advise on directly, there's no safely generic response.
If your prescription is through a Wegovy weight-management treatment that includes a pre-filled pen, the technique differs from syringe use, and a full guide to injecting semaglutide covers both formats. For those new to self-injection generally, self-injection guidance for semaglutide walks through the confidence side as much as the mechanics, first injections are nerve-wracking for most people, and that's entirely normal.
If you're not yet on treatment and want to understand your options, you can start a free consultation with our clinical team. A GPhC-registered prescriber reads every submission the same day and will let you know whether semaglutide is suitable for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.